These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 8084291

  • 1. Pregnancy in a patient with homozygous familial hypercholesterolemia treated with long-term low-density lipoprotein apheresis.
    Kroon AA, Swinkels DW, van Dongen PW, Stalenhoef AF.
    Metabolism; 1994 Sep; 43(9):1164-70. PubMed ID: 8084291
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pregnancy in a patient with homozygous familial hypercholesterolemia undergoing low-density lipoprotein apheresis by dextran sulfate adsorption.
    Teruel JL, Lasunción MA, Navarro JF, Carrero P, Ortuño J.
    Metabolism; 1995 Jul; 44(7):929-33. PubMed ID: 7616853
    [Abstract] [Full Text] [Related]

  • 4. Treatment of homozygous familial hypercholesterolemia with low density lipoprotein apheresis: a 4 year follow-up study.
    Fadul JE, Vessby B, Wikström B, Danielson BG.
    Artif Organs; 1997 May; 21(5):364-8. PubMed ID: 9129767
    [Abstract] [Full Text] [Related]

  • 5. The effect of atorvastatin on serum lipids and lipoproteins in patients with homozyous familial hypercholesterolemia undergoing LDL-apheresis therapy.
    Yamamoto A, Harada-Shiba M, Kawaguchi A, Oi K, Kubo H, Sakai S, Mikami Y, Imai T, Ito T, Kato H, Endo M, Sato I, Suzuki Y, Hori H.
    Atherosclerosis; 2000 Nov; 153(1):89-98. PubMed ID: 11058703
    [Abstract] [Full Text] [Related]

  • 6. LDL apheresis in a homozygous familial hypercholesterolemic child aged 4.5.
    Stefanutti C, Notarbartolo A, Colloridi V, Nigri A, Vivenzio A, Bertolini S, Bosco G, Berni A, Di Giacomo S, Mazzarella B.
    Artif Organs; 1997 Oct; 21(10):1126-7. PubMed ID: 9335372
    [Abstract] [Full Text] [Related]

  • 7. Cholesterol efflux mediators in homozygous familial hypercholesterolemia patients on low-density lipoprotein apheresis.
    Nenseter MS, Narverud I, Græsdal A, Bogsrud MP, Aukrust P, Retterstøl K, Ose L, Halvorsen B, Holven KB.
    J Clin Lipidol; 2013 Oct; 7(2):109-16. PubMed ID: 23415429
    [Abstract] [Full Text] [Related]

  • 8. Role of LDL apheresis in a case of homozygous familial hypercholesterolemia.
    Naveen T, Biswas A, Wig N, Soneja M, Jorwal P, Durga CS, Singla P, Chaudhary C, Baitha U.
    Drug Discov Ther; 2019 Oct; 13(1):59-61. PubMed ID: 30880324
    [Abstract] [Full Text] [Related]

  • 9. Reduction of lipoprotein(a) by LDL-apheresis using a dextran sulfate cellulose column in patients with familial hypercholesterolemia.
    Koizumi J, Koizumi I, Uno Y, Inazu A, Kajinami K, Haraki T, Yagi K, Kamon N, Miyamoto S, Takegoshi T.
    Atherosclerosis; 1993 Apr; 100(1):65-74. PubMed ID: 8318064
    [Abstract] [Full Text] [Related]

  • 10. Decreased low-density lipoprotein oxidation after repeated selective apheresis in homozygous familial hypercholesterolemia.
    Napoli C, Ambrosio G, Scarpato N, Corso G, Palumbo G, D'Armiento FP, Mancini FP, Malorni A, Formisano S, Ruocco A, Calí A, Chiariello M.
    Am Heart J; 1997 May; 133(5):585-95. PubMed ID: 9141382
    [Abstract] [Full Text] [Related]

  • 11. Pregnancy in homozygous familial hypercholesterolemia--Importance of LDL-apheresis.
    Blaha M, Lanska M, Blaha V, Boudys L, Zak P.
    Atheroscler Suppl; 2015 May; 18():134-9. PubMed ID: 25936317
    [Abstract] [Full Text] [Related]

  • 12. Treatment of children with homozygous familial hypercholesterolemia: safety and efficacy of low-density lipoprotein apheresis.
    Uauy R, Zwiener RJ, Phillips MJ, Petruska ML, Bilheimer DW.
    J Pediatr; 1992 Jun; 120(6):892-8. PubMed ID: 1593349
    [Abstract] [Full Text] [Related]

  • 13. Low-density lipoprotein apheresis as long-term treatment for children with homozygous familial hypercholesterolemia.
    Zwiener RJ, Uauy R, Petruska ML, Huet BA.
    J Pediatr; 1995 May; 126(5 Pt 1):728-35. PubMed ID: 7751996
    [Abstract] [Full Text] [Related]

  • 14. Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia. Hokuriku-FH-LDL-Apheresis Study Group.
    Mabuchi H, Koizumi J, Shimizu M, Kajinami K, Miyamoto S, Ueda K, Takegoshi T.
    Am J Cardiol; 1998 Dec 15; 82(12):1489-95. PubMed ID: 9874053
    [Abstract] [Full Text] [Related]

  • 15. Low-density lipoprotein apheresis in a patient aged 3.5 years.
    Stefanutti C, Di Giacomo S, Vivenzio A, Colloridi V, Bosco G, Berni A, Rabbone I, Cerutti F, Bertolini S.
    Acta Paediatr; 2001 Jun 15; 90(6):694-701. PubMed ID: 11440106
    [Abstract] [Full Text] [Related]

  • 16. [Serum lipoprotein (a) levels during treatment with LDL apheresis for homozygous familial hypercholesterolemia].
    Lasunción MA, Teruel JL, Alvarez JJ, Gómez-Coronado D, Ortuño J, Herrera E.
    Med Clin (Barc); 1992 Oct 31; 99(14):541-4. PubMed ID: 1434990
    [Abstract] [Full Text] [Related]

  • 17. Long-term effect of low-density lipoprotein apheresis on plasma lipoproteins and coronary heart disease in native vessels and coronary bypass in severe heterozygous familial hypercholesterolemia.
    Richter WO, Donner MG, Höfling B, Schwandt P.
    Metabolism; 1998 Jul 31; 47(7):863-8. PubMed ID: 9667236
    [Abstract] [Full Text] [Related]

  • 18. Long-term effects of LDL apheresis in patients with severe hypercholesterolemia.
    Sachais BS, Katz J, Ross J, Rader DJ.
    J Clin Apher; 2005 Dec 31; 20(4):252-5. PubMed ID: 15880364
    [Abstract] [Full Text] [Related]

  • 19. Long-term effects of low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system. Liposorber Study Group.
    Gordon BR, Kelsey SF, Dau PC, Gotto AM, Graham K, Illingworth DR, Isaacsohn J, Jones PH, Leitman SF, Saal SD, Stein EA, Stern TN, Troendle A, Zwiener RJ.
    Am J Cardiol; 1998 Feb 15; 81(4):407-11. PubMed ID: 9485128
    [Abstract] [Full Text] [Related]

  • 20. Single LDL apheresis improves serum remnant-like particle-cholesterol, C-reactive protein, and malondialdehyde-modified-low-density lipoprotein concentrations in Japanese hypercholesterolemic subjects.
    Kobayashi J, Katsube S, Shimoda M, Furuhashi K, Kitano S, Masuda M, Maruyama T, Shinomiya M.
    Clin Chim Acta; 2002 Jul 15; 321(1-2):107-12. PubMed ID: 12031599
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.